Evotec
Presença
Executivos
Veja o organograma con seus 42 executivos principais
Biografias mais buscadas da Evotec
- Mario Polywka, Interim Chief Executive Officer and Director (retir...
- Elaine Sullivan, Member of the Supervisory Board
- Camilla Languille, Director
Recentes movimentos de executivos em Evotec
- Mario Polywka, Interim Chief Executive Officer and Director, irá se aposentar em 30 de jun. de 2024 (Notícia publicada em 28 de abril de 2024).
- Christian Wojczewski ingressará na Companhia como Chief Executive Officer em 1 de jul. de 2024 (Notícia publicada em 25 de abril de 2024).
- Aurélie Dalbiez ingressará na Companhia como Chief People Officer em 15 de jun. de 2024 (Notícia publicada em 17 de abril de 2024).
Clique aqui para ver outras movimentos em Evotec
Criar um alerta
para seguir os movimentos de executivos da Evotec.
Farmacêutica
Evotec possui 1.860 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Evotec
- Bayer and Evotec collaborate to advance precision cardiology - Evotec Website (English)
- Evotec SE to announce results for first quarter 2024 on 22 may 2024 - Evotec Website (English)
- Evotec partner Kazia reports the successful completion of the EVT801 Phase 1 clinical trial in advanced cancer patients - Evotec Website (English)
- Breakpoint Therapeutics Announces Development Candidate Nomination and Start of IND-Enabling Activities of Potential Best-in-Class Polymerase Theta (Pol θ / POLQ) Inhibitor - Evotec
- Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline - Evotec
- Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic - Evotec
- Developing novel strategies against tuberculosis and malaria - Evotec
- Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV - Evotec
- Evotec SE: Invitation to Conference Call - Evotec
- Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb - Evotec
- View more press releases Close
Redes sociais sobre Evotec
- Evotec na Wikipedia, Google News e Yahoo Finance
- Evotec na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Mario Polywka 
Ligue para a Evotec em +49 ...
